臨床試験を検索:30 mg CVL-231 目標放出、Fed
合計211件
-
Reckitt Benckiser Healthcare (UK) LimitedPremier Research Group plc完了
-
Merck Sharp & Dohme LLC完了
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...募集
-
Auzone Biological Technology Pty LtdTIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd完了
-
Diurnal LimitedNational Institutes of Health Clinical Center (CC)完了
-
Unither Pharmaceuticals, FranceEXCELYA Bordeaux完了
-
Mohamed SaadAbbott Nutrition; University of Louisville完了
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...募集
-
Dexa Medica Group完了
-
Overseas Pharmaceuticals, Ltd.Virginia Contract Research Organization Co., Ltd.終了しました
-
Jules Bordet Institute積極的、募集していない直腸がんステージ II | 直腸がんステージ IIIベルギー, フランス
-
University of DhakaUniversity of Dundee; Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine...完了
-
GlaxoSmithKline完了
-
IRCCS San RaffaeleMenarini International Operations Luxembourg SA完了
-
Charleston Laboratories, Inc完了
-
University of MichiganFood and Drug Administration (FDA)募集
-
Tris Pharma, Inc.Massachusetts General Hospital; Massachusetts Institute of Technology完了
-
Medicines for Malaria VentureSanaria Inc.; Institute of Tropical Medicine, Belgium; Iqvia Pty Ltd; SGS Life Sciences, a division... と他の協力者完了
-
Boehringer Ingelheim完了
-
Torrent Pharmaceuticals Limited完了
-
Torrent Pharmaceuticals Limited完了
-
Celyad Oncology SAIQVIA Biotech完了
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital... と他の協力者募集